K Danø

1.5k citations
8 papers · 1.3k · h-index 8

Impact in

Papers in

K Danø

8 papers receiving 1.3k citations

Peers

K Danø
Comparison fields: 5 of 75
  • Immunology and Allergy 549
  • Cancer Research 854
  • Hematology 249
  • Oncology 607
  • Cell Biology 167
Replace Julie C. Lively with:
Julie C. Lively United States
Yves A. De Clerck United States
Anna T. Levy United States
J Pöllänen Finland
Sirpa Salo Finland
John Nip United States
Salomón Matías‐Román Spain
Lisa M. Bafetti United States
Ruediger Volk United States
Heli Valtanen Finland
K Danø relative to Julie C. Lively United States Julie C. Lively's profile →
Citations per field
00.5×1.5×
Julie C. Lively · 1×
Citations per year

Countries citing papers authored by K Danø

Since Specialization
Citations

This map shows the geographic impact of K Danø's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Danø with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Danø more than expected).

Fields of papers citing papers by K Danø

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Danø. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Danø. The network helps show where K Danø may publish in the future.

Co-authors

The 21 scholars most cited alongside K Danø, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with K Danø Line = papers co-authored together K Danø links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1
High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis.
1993353
2
Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas.
1995341
3
Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization.
1992292
4 1996147
5
Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer.
199785
6
Sensitive and specific enzyme-linked immunosorbent assay for urokinase-type plasminogen activator and its application to plasma from patients with breast cancer.
198866
7 199616
8 199210

About K Danø

K Danø is a scholar working on Cancer Research, Molecular Biology, Oncology, Hematology and Immunology and Allergy, having authored 8 papers that have together received 1.3k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (7 papers), Peptidase Inhibition and Analysis (3 papers), TGF-β signaling in diseases (2 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers), Cell Adhesion Molecules Research (2 papers), Oral Health Pathology and Treatment (1 paper), Antioxidant Activity and Oxidative Stress (1 paper) and Wnt/β-catenin signaling in development and cancer (1 paper). The work is most often cited by research in Immunology and Allergy (549 citations), Cancer Research (854 citations), Hematology (249 citations), Oncology (607 citations) and Cell Biology (167 citations). K Danø has collaborated with scholars based in Denmark. Frequent co-authors include Karl Tryggvason, Elisabeth Ralfkiær, Charles Pyke, J Grøndahl-Hansen, John Rømer, Sirpa Salo, I. J. Christensen, Christian Rosenquist, M Blichert-Toft and H.T. Mouridsen. Their work appears in journals such as FEBS Letters, International Journal of Cancer and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact